ENDS EVALI VALI THCVALI: Difference between revisions
| Line 117: | Line 117: | ||
==Journals== | ==Journals== | ||
===2021: [https://pubmed.ncbi.nlm.nih.gov/34694926/ Lessons Learned From the E-cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) Outbreak Response, Minnesota, 2019-2020]=== | |||
*Minnesota was among the first states in which health care providers reported suspected EVALI cases, and MDH responded quickly and effectively to the EVALI outbreak. Despite multiple challenges, MDH’s response had many successes, primarily collaboration with internal and external partners. Minnesota’s experience with the EVALI outbreak provided lessons learned that can be used to strengthen future responses to outbreaks of noncommunicable diseases. Although US public health agencies are well versed in handling outbreaks of infectious diseases, now is the time to ensure adequate capacity to respond to other types of outbreaks. | |||
**Citation: Wiens T, Taylor J, Cole C, Saravia S, Peterson J, Lunda M, Margetta J, D'Heilly P, Holzbauer S, Lynfield R. Lessons Learned From the E-cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) Outbreak Response, Minnesota, 2019-2020. Public Health Rep. 2022 Nov-Dec;137(6):1053-1060. doi: 10.1177/00333549211051394. Epub 2021 Oct 25. PMID: 34694926; PMCID: PMC9574319. | |||
***Acknowledgment: Support for this project was provided by the Council of State and Territorial Epidemiologists through the Applied Epidemiology Fellowship Program. | |||
===2020: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151740/ Analysis of Cannabinoid-Containing Fluids in Illicit Vaping Cartridges Recovered from Pulmonary Injury Patients: Identification of Vitamin E Acetate as a Major Diluent]=== | ===2020: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151740/ Analysis of Cannabinoid-Containing Fluids in Illicit Vaping Cartridges Recovered from Pulmonary Injury Patients: Identification of Vitamin E Acetate as a Major Diluent]=== | ||
*As of December 12, 2019, the Wadsworth Center has analyzed 206 vaporizer fluids from 61 NYS EVALI cases. Of these, 147 contained THC, and 59 contained nicotine. Of the 147 THC-containing fluids, 101 (69%) contained VEA. There is additional evidence of a strong association of VEA with EVALI. In the initial analyses of bronchoalveolar lavage fluids from EVALI patients, 28 of 28 fluids contained vitamin E acetate. | *As of December 12, 2019, the Wadsworth Center has analyzed 206 vaporizer fluids from 61 NYS EVALI cases. Of these, 147 contained THC, and 59 contained nicotine. Of the 147 THC-containing fluids, 101 (69%) contained VEA. There is additional evidence of a strong association of VEA with EVALI. In the initial analyses of bronchoalveolar lavage fluids from EVALI patients, 28 of 28 fluids contained vitamin E acetate. | ||